Expertise across Parliament, academia and practice.
Our co-chairs, board and Policy Council are unremunerated and have no financial interest in the Centre.
Charlotte Nichols MP
Labour, Warrington North
An MP since 2019 and a vocal advocate for better drug policy — in particular championing the campaign for rescheduling psilocybin and drug-related deaths. Our chair has a proven track record of parliamentary expertise and integrity.
Our team
The staff who run the Centre's research and parliamentary engagement.Sam Lawes
Sam joined the CEBDP in November 2022 with a background in early years policy, trauma-informed practice and patient voice advocacy. Much of his expertise comes from four years at early years charity WAVE Trust, where he co-created a trauma-informed training programme based on the latest global research, gained expertise in pathways to disadvantage and saw the overwhelming evidence for a public health approach to drugs policy.
He believes the paucity of mental health support in our country feeds directly into vulnerable people seeking self-medication by other means, including misuse of alcohol and other drugs. He has a private psychotherapy practice.
Timothy Davis
As Psilocybin Rescheduling Project manager, Timothy collates and presents the evidence for a change in psilocybin's status as a Schedule 1 substance under the Misuse of Drugs Regulations 2001 — using psilocybin as indicative of a wider need to reassess many other Schedule 1 substances, such as MDMA. He also contributes to research on routes of access to medical cannabis, and is training as a psychoanalytic psychotherapist with the SITE for Contemporary Psychoanalysis.
Timothy is a guide on the psilocybin for treatment-resistant depression trials at King's College London and a welfare and harm reduction manager at music festivals in the UK and abroad. He holds an MA in Psychoanalytic Studies from Birkbeck College and a BA (Hons) in Philosophy and Religion from the University of Kent, where he was president of the psychedelic society for three years.
Alex Piot
Alex trained as a neuropsychopharmacologist with a focus on the use of controlled substances for treating mental health disorders. His interest began with research on the interaction of ovarian hormones and ketamine in depression treatment, followed by studies on the synaptic correlates of benzodiazepine tolerance and brain morphology changes from repeated ayahuasca use.
He is pursuing a Wellcome Trust-funded PhD in Mental Health Science at UCL, and studied Experimental Pharmacology and Therapeutics and Clinical Neuroscience at UCL before joining the CEBDP in December 2022.
Our patrons
Jim Shannon MP
MP for Strangford since 2010. Led a Westminster Hall debate on reducing drug deaths.
Siân Berry MP
MP for Brighton Pavilion and long-standing advocate for evidence-led drug policy.
Jeff Smith MP
MP for Manchester Withington since 2015 and a consistent voice for reform.























